Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-24

FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)

View source ↗

Summary

FDA approved a supplemental application for Ozempic to include the oral formulation of semaglutide. This adds an oral option alongside the existing injectable f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OZEMPIC (semaglutide)

Snippet

SUPPL AP for OZEMPIC (ORAL SEMAGLUTIDE)